These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11739854)

  • 1. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study.
    Stewart R
    Neurology; 2001 Dec; 57(11):2149. PubMed ID: 11739854
    [No Abstract]   [Full Text] [Related]  

  • 2. White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype.
    Bronge L; Fernaeus SE; Blomberg M; Ingelson M; Lannfelt L; Isberg B; Wahlund LO
    Dement Geriatr Cogn Disord; 1999; 10(2):89-96. PubMed ID: 10026381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E epsilon4 allele and clinically defined vascular depression.
    Rigaud AS; Latour F; Moulin F; Forette F; Traykov L; Boller F
    Arch Gen Psychiatry; 2002 Mar; 59(3):290-1. PubMed ID: 11879173
    [No Abstract]   [Full Text] [Related]  

  • 4. A practical method to predict rate of cognitive decline in mild to moderate Alzheimer's disease.
    Matsui T; Higuchi M; Okamura N; Arai H; Sasaki H
    Neurology; 1999 Dec; 53(9):2208-9. PubMed ID: 10599813
    [No Abstract]   [Full Text] [Related]  

  • 5. Head trauma and Alzheimer's disease.
    Nandoe RD; Scheltens P; Eikelenboom P
    J Alzheimers Dis; 2002 Aug; 4(4):303-8. PubMed ID: 12446932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Cognitive stress test" may yield early clues of preclinical AD.
    Hotz RL
    Am J Alzheimers Dis Other Demen; 2001; 16(1):9-10. PubMed ID: 11416956
    [No Abstract]   [Full Text] [Related]  

  • 7. [The apolipoprotein E gene and Alzheimer disease phenotype].
    Kurz A; Egensperger R; Lautenschlager N; Haupt M; Altland K; Graeber MB; Müller U
    Z Gerontol Geriatr; 1995; 28(3):195-9. PubMed ID: 7664194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.
    Visser PJ; Scheltens P; Pelgrim E; Verhey FR;
    Dement Geriatr Cogn Disord; 2005; 19(2-3):126-33. PubMed ID: 15627759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alzheimer dementia and normal aging. Clinical, neuroradiologic, neurophysiologic and molecular biology follow-up data].
    Förstl H; Sattel H; Sarochan M; Besthom C; Czech C; Daniel S; Geiger-Kabisch C; Hentschel F; Zerfass R; Beyreuther K
    Nervenarzt; 1996 Sep; 67(9):730-8. PubMed ID: 8992370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain signals of dementia?
    Harv Ment Health Lett; 2000 Nov; 17(5):6. PubMed ID: 11063563
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease.
    van Gool WA
    Ann N Y Acad Sci; 1996 Dec; 802():79-91. PubMed ID: 8993487
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein E Genotyping in Alzheimer's Disease. Chicago, Illinois, October 21-22, 1995. Proceedings.
    Ann N Y Acad Sci; 1996 Dec; 802():1-224. PubMed ID: 9012314
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease.
    Sawada H; Udaka F; Izumi Y; Nishinaka K; Kawakami H; Nakamura S; Kameyama M
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):653-6. PubMed ID: 10766901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction for unimpaired subjects is different from diagnosis of demented patients.
    Roses AD; Saunders AM
    Ann Neurol; 1997 Mar; 41(3):414-6. PubMed ID: 9066367
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of preclinical Alzheimer's disease.
    Skoog I
    N Engl J Med; 2000 Aug; 343(7):502-3. PubMed ID: 10944568
    [No Abstract]   [Full Text] [Related]  

  • 19. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?
    Doody RS; Azher SN; Haykal HA; Dunn JK; Liao T; Schneider L
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):668-71. PubMed ID: 11032626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoproteins E and C1 and brain morphology in memory impaired elders.
    Serra-Grabulosa JM; Salgado-Pineda P; Junqué C; Solé-Padullés C; Moral P; López-Alomar A; López T; López-Guillén A; Bargalló N; Mercader JM; Clemente IC; Bartrés-Faz D
    Neurogenetics; 2003 Apr; 4(3):141-6. PubMed ID: 12736801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.